Form 4 for NRC NRC HEALTH
Accepted 2023-02-28 00:00:00 ET · period of report 2023-02-24 · accession 0001567619-23-003958 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-02-28 | 2023-02-24+ | NRC | Karas Kevin R | CFO, SVP Fin, Treas, Secy | S - Sale | $45.68 | -11.9K | 10.1K | -54% | -$544.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-28 | S | D | 2,319 | $45.34 | 5,384 | D | — | — | (F3) The price in Column 4 is a weighted average price. The prices actually ranged from $45.13 to $45.62, inclusive. |
| 2 | Common | Common Stock | 2023-02-27 | S | D | 2,437 | $45.51 | 7,703 | D | — | — | (F2) The price in Column 4 is a weighted average price. The prices actually ranged from $45.00 to $45.74, inclusive. |
| 3 | Common | Common Stock | 2023-02-24 | S | D | 7,156 | $45.84 | 10,140 | D | — | — | (F1) The price in Column 4 is a weighted average price. The prices actually ranged from $45.55 to $45.95, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1), (2), and (3) of this Form 4. |